华纳药厂
(688799)
| 流通市值：65.12亿 | | | 总市值：65.12亿 |
| 流通股本：1.31亿 | | | 总股本：1.31亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 195,941,291.03 | 185,397,006.45 | 124,512,903.47 | 177,739,940.58 |
| 交易性金融资产 | 100,000,000 | 10,000,000 | 180,000,000 | 183,000,000 |
| 应收票据及应收账款 | 207,704,605.86 | 207,501,989.76 | 195,737,160.44 | 187,658,667.02 |
| 其中：应收票据 | 12,283,479.87 | 14,182,092.35 | 29,008,924.84 | 19,351,867.04 |
| 应收账款 | 195,421,125.99 | 193,319,897.41 | 166,728,235.6 | 168,306,799.98 |
| 应收款项融资 | 25,480,350.58 | 19,982,069.53 | 25,172,030.49 | 38,531,030.56 |
| 预付款项 | 21,293,191.43 | 19,616,494.16 | 33,690,712 | 15,220,329.88 |
| 其他应收款合计 | 12,643,226.44 | 3,929,786.82 | 10,928,234.46 | 16,497,508.66 |
| 存货 | 410,995,449.94 | 414,059,825.52 | 416,299,061.19 | 412,431,462.31 |
| 其他流动资产 | 452,242,636.18 | 492,635,433.89 | 403,345,869.34 | 402,193,934.86 |
| 流动资产合计 | 1,426,300,751.46 | 1,353,122,606.13 | 1,389,685,971.39 | 1,433,272,873.87 |
| 非流动资产: | | | | |
| 长期股权投资 | 202,082,133.12 | 67,605,243.72 | 72,143,111.74 | 43,494,035.65 |
| 投资性房地产 | 5,617,725.47 | 5,659,846.22 | 5,701,976.44 | 5,744,125.6 |
| 固定资产 | 499,886,589.19 | 519,517,089.98 | 530,360,239.76 | 543,944,507.26 |
| 在建工程 | 275,496,023.03 | 228,776,605.43 | 138,052,477.3 | 143,055,676.31 |
| 无形资产 | 165,276,788.3 | 182,507,217.73 | 184,300,743.98 | 186,093,770.23 |
| 开发支出 | 9,863,428.92 | 5,724,446.37 | - | - |
| 商誉 | - | 32,381,982.12 | 32,381,982.12 | 32,381,982.12 |
| 长期待摊费用 | 8,933,675.33 | 10,125,138.94 | 9,877,856.86 | 10,441,791.88 |
| 递延所得税资产 | 28,516,873.81 | 32,248,332.93 | 35,520,848.46 | 39,813,280.04 |
| 其他非流动资产 | 158,870,186.96 | 87,938,079.94 | 72,826,812.04 | 21,399,101.82 |
| 非流动资产合计 | 1,354,543,424.13 | 1,172,483,983.38 | 1,081,166,048.7 | 1,026,368,270.91 |
| 资产总计 | 2,780,844,175.59 | 2,525,606,589.51 | 2,470,852,020.09 | 2,459,641,144.78 |
| 流动负债: | | | | |
| 短期借款 | - | - | 2,647,715.21 | 3,770,257.75 |
| 应付票据及应付账款 | 99,036,824.15 | 109,027,443.81 | 120,412,390.36 | 192,278,534.77 |
| 其中：应付票据 | - | - | 20,000,000 | 32,359,369.21 |
| 应付账款 | 99,036,824.15 | 109,027,443.81 | 100,412,390.36 | 159,919,165.56 |
| 预收款项 | 17,547,105.55 | 15,822,933.53 | 9,142,383.57 | 12,539,485.23 |
| 合同负债 | 78,337,291.83 | 81,958,355.07 | 89,292,284.68 | 76,450,375.1 |
| 应付职工薪酬 | 15,169,366.36 | 14,453,001.72 | 15,089,355.48 | 23,435,305.73 |
| 应交税费 | 18,737,369.48 | 12,306,237.37 | 19,780,116.28 | 16,134,036.16 |
| 其他应付款合计 | 88,765,151.79 | 88,059,279.15 | 72,618,637.49 | 74,619,122.09 |
| 一年内到期的非流动负债 | 229,465.24 | 139,981.58 | 230,849.61 | 51,124.91 |
| 其他流动负债 | 16,939,991.02 | 14,270,823.46 | 29,740,359.07 | 19,745,080.46 |
| 流动负债合计 | 334,762,565.42 | 336,038,055.69 | 358,954,091.75 | 419,023,322.2 |
| 非流动负债: | | | | |
| 长期借款 | 352,180,598.74 | 235,673,102.52 | 134,461,194 | 113,928,338 |
| 预计负债 | - | - | 5,282,000 | 5,282,000 |
| 递延收益 | 101,780,781.48 | 95,744,971.86 | 97,415,188.94 | 98,804,349.74 |
| 递延所得税负债 | - | - | - | 24,102.53 |
| 非流动负债合计 | 453,961,380.22 | 331,418,074.38 | 237,158,382.94 | 218,038,790.27 |
| 负债合计 | 788,723,945.64 | 667,456,130.07 | 596,112,474.69 | 637,062,112.47 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 131,320,000 | 131,320,000 | 93,800,000 | 93,800,000 |
| 资本公积 | 850,688,125.6 | 835,869,925.6 | 858,606,314.4 | 850,338,381.88 |
| 盈余公积 | 46,900,000 | 46,900,000 | 46,900,000 | 46,900,000 |
| 未分配利润 | 963,212,104.35 | 827,204,059.21 | 853,547,530.68 | 812,368,554.11 |
| 归属于母公司股东权益合计 | 1,992,120,229.95 | 1,841,293,984.81 | 1,852,853,845.08 | 1,803,406,935.99 |
| 少数股东权益 | - | 16,856,474.63 | 21,885,700.32 | 19,172,096.32 |
| 股东权益合计 | 1,992,120,229.95 | 1,858,150,459.44 | 1,874,739,545.4 | 1,822,579,032.31 |
| 负债和股东权益合计 | 2,780,844,175.59 | 2,525,606,589.51 | 2,470,852,020.09 | 2,459,641,144.78 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-22 | 2025-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |